2025 HCPCS Code G9210
Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
TAGS: period antiviral patients hepatitis whose treatment performed weeks discontinued during initiation prior patient documented medical testing quantitativeNotice | HCPCS G9210 terminated on December 31, 2016. |
Short Description | No hepc rna after med docrsn |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | January 01, 2014 |
HCPCS Action Effective Date | January 01, 2017 |
HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9053 - Onc expectant management pt
- G9054 - Onc supervision palliative
- G9055 - Onc visit unspecified nos
- G9056 - Onc prac mgmt adheres guide
- G9057 - Onc pract mgmt differs trial
- G9058 - Onc prac mgmt disagree w/gui
- G9059 - Onc prac mgmt pt opt alterna
- G9060 - Onc prac mgmt dif pt comorb
- G9061 - Onc prac cond noadd by guide
- G9062 - Onc prac guide differs nos
- G9063 - Onc dx nsclc stgi no progres
- G9064 - Onc dx nsclc stg2 no progres
- G9065 - Onc dx nsclc stg3a no progre
- G9066 - Onc dx nsclc stg3b-4 metasta
- G9067 - Onc dx nsclc dx unknown nos
- G9068 - Onc dx sclc/nsclc limited
- G9069 - Onc dx sclc/nsclc ext at dx
- G9070 - Onc dx sclc/nsclc ext unknwn
- G9071 - Onc dx brst stg1-2b hr,nopro
- G9072 - Onc dx brst stg1-2 noprogres